NRx Pharmaceuticals, Inc. (NRXPW)

Market Cap	34.68M
Revenue (ttm)	n/a
Net Income (ttm)	-25.13M
Shares Out	16.92M
EPS (ttm)	-2.36
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	257
Open	0.0711
Previous Close	0.0721
Day's Range	0.0711 - 0.0711
52-Week Range	0.0711 - 0.0711
Beta	1.22
Analysts	n/a
Price Target	n/a
Earnings Date	Mar 28, 2025

About NRXPW

NRx Pharmaceuticals, Inc., a clinical-stage bio-pharmaceutical company, develops novel therapeutics for the treatment of central nervous system disorders, including suicidal depression, post-traumatic stress disorder, and chronic pain. Its products include NRX-101 (D-cycloserine/Lurasidone), an oral, fixed dosed combination of D-cycloserine and lurasidone that earned food and drug administration-designated breakthrough therapy for suicidal treatment-resistant bipolar depression; and NRX-100 (ketamine), which has been awarded FDA fast track desi...

• Industry: Biotechnology
• Sector: Healthcare
• Founded: 2015
• Country: United States
• Stock Exchange: NASDAQ
• Ticker Symbol: NRXPW
• Website: https://www.nrxpharma.com